UK markets closed

Alzamend Neuro, Inc. (ALZN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.4456+0.0056 (+1.27%)
As of 01:11PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/04/2022
30/04/2021
30/04/2020
30/04/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
5,444
5,201
1,311
1,069
3,700
Selling general and administrative
7,128
7,118
3,641
3,355
1,309
Total operating expenses
12,571
12,320
4,952
4,424
5,009
Operating income or loss
-12,571
-12,320
-4,952
-4,424
-5,009
Interest expense
22.021
46.524
158.803
-
-
Total other income/expenses net
-
4
62.418
-
-
Income before tax
-12,589
-12,362
-5,047
-4,410
-4,862
Income from continuing operations
-12,589
-12,362
-5,047
-4,410
-4,862
Net income
-12,589
-12,362
-5,047
-4,410
-4,862
Net income available to common shareholders
-12,589
-12,362
-5,047
-4,410
-4,862
Basic EPS
-
-0.14
-0.06
-0.05
-0.05
Diluted EPS
-
-0.14
-0.06
-0.05
-0.05
Basic average shares
-
89,095
84,930
88,754
88,754
Diluted average shares
-
89,095
84,930
88,754
88,754
EBITDA
-
-12,312
-4,888
-4,424
-5,009